Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,164 | 3,111 | 4,193 | 5,490 | 6,258 |
| TOTAL | $2,719 | $3,388 | $4,538 | $5,725 | $6,491 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 0 | 2 | 3 |
| Intangibles | 666 | 705 | 745 | 784 | 823 |
| TOTAL | $666 | $705 | $745 | $786 | $826 |
| Total Assets | $3,385 | $4,093 | $5,283 | $6,511 | $7,317 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 124 | 225 | 112 | 253 | 88 |
| TOTAL | $282 | $471 | $430 | $288 | $100 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $282 | $471 | $430 | $288 | $100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -186,185 | -185,665 | -184,431 | -183,040 | -182,018 |
| TOTAL | $3,103 | $3,622 | $4,853 | $6,223 | $7,217 |
| Total Liabilities And Equity | $3,385 | $4,093 | $5,283 | $6,511 | $7,317 |